HighTower Advisors
SNY icon

HighTower Advisors’s Sanofi SNY Stock Holding History

HighTower Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,000
Closed -$3K – 2346
2017
Q2 		$3K Buy
+1,000
New +$47.8K ﹤0.01% 2171

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

HighTower Advisors's SNY Position: Q2 2026 in Review

HighTower Advisors reduced its Sanofi (SNY) stake by 8.3% in Q2 2026, selling an estimated $238K and leaving 58,761 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

HighTower Advisors first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. The position peaked at $17M in Q3 2023. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • HighTower Advisors held 58,761 shares of Sanofi worth $2.51M as of Q2 2026.
  • HighTower Advisors sold 5,335 Sanofi shares in Q2 2026, an estimated $238K.
  • Sanofi made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1626 holding.
  • HighTower Advisors first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
  • HighTower Advisors's Sanofi position peaked at $17M in Q3 2023.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.